Covovax for 7-12-year-olds: Panel seeks more data

SII had presented interim safety and immunogenicity data of a two-month period after the second dose of Covovax was administered to 225 participants in the 7-12-year age group.

from Industry-Economic Times
Read The Rest:economictimes...